Botulinum Toxin - Recent Topics and Applications [Working Title]最新文献

筛选

英文中文

Quality of Life in Neurogenic Bladder Patients and Improvement after Botulinum Toxin Injection 神经源性膀胱患者注射肉毒毒素后的生活质量及改善

Botulinum Toxin - Recent Topics and Applications [Working Title] Pub Date : 2022-01-29 DOI: 10.5772/intechopen.102384

G. Palleschi, A. Cardi

{"title":"Quality of Life in Neurogenic Bladder Patients and Improvement after Botulinum Toxin Injection","authors":"G. Palleschi, A. Cardi","doi":"10.5772/intechopen.102384","DOIUrl":"https://doi.org/10.5772/intechopen.102384","url":null,"abstract":"Various neurogenic conditions may determine an altered function of the bladder and urethral sphincters leading to urinary symptoms. Among these symptoms, loss of urine is considered the most bothersome, and recent literature has proposed that urinary incontinence and poor quality of life should be considered as associated conditions. Urinary incontinence is responsible for reducing the enjoyment of life, including loss of self-confidence and limitation of social activity; it is also associated with anxiety, depression, and deterioration in sexual life, and reduced physical activity. Conservative treatments represent a first-line therapeutic approach to neurogenic urinary disorders, followed by oral medications. However, these treatments often do not provide complete recovery from symptoms, especially from urinary incontinence. Onabotulimun toxin A has proven to be safe and effective for treating neurogenic urinary incontinence and its use is associated with a strong improvement of patients’ quality of life. Furthermore, this treatment lowers the risk of severe complications to the upper urinary tract, reducing the need for hospitalization. Quality of life improvement as well as clinical efficacy must be considered targets of the therapy, and the use of onabotulimun toxin A for treating neurogenic urinary incontinence reaches both these goals.","PeriodicalId":397025,"journal":{"name":"Botulinum Toxin - Recent Topics and Applications [Working Title]","volume":"143 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122917766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gummy Smile and Treatment with Botulinum Toxin Type A (Botox) A型肉毒杆菌毒素(Botox)的治疗

Botulinum Toxin - Recent Topics and Applications [Working Title] Pub Date : 2022-01-25 DOI: 10.5772/intechopen.102341

I. Katbeh, Mohammad Osama Makkeiah, T. Kosyreva, L. Saneeva

{"title":"Gummy Smile and Treatment with Botulinum Toxin Type A (Botox)","authors":"I. Katbeh, Mohammad Osama Makkeiah, T. Kosyreva, L. Saneeva","doi":"10.5772/intechopen.102341","DOIUrl":"https://doi.org/10.5772/intechopen.102341","url":null,"abstract":"A smile plays an important role in determining a person’s initial impression, and its assessment has become integral to clinical evaluation. A smile with an esthetic appearance should be symmetrical and should reveal less than 2 mm of gums when smiling. A gingival smile, gummy smile, or high smile line, is defined as the number of excess gums on the upper jaw exposed. This may have some serious psychological repercussions on the patient, which may sometimes lead them to conceal their smile to avoid “embarrassment.” One of the most common methods of treating a gingival smile resulting from an overactive lip is lip reposition as a surgical procedure and the injection of type A (Botox) toxin as an injectable inhibitor of muscle action. However, many patients refrain from surgical treatment because of fear of complications and pain. In this case, injections of botulinum toxin group A are an excellent alternative to surgery. The injection of botulinum toxin takes less time and with the correct dosage and compliance with the protocol of its administration causes much fewer complications. The study presented here is devoted to the disclosure of the potential of this tool in esthetic dentistry.","PeriodicalId":397025,"journal":{"name":"Botulinum Toxin - Recent Topics and Applications [Working Title]","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130955468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Pharmacology of Botulinum Toxin Type A A型肉毒毒素的药理学研究

Botulinum Toxin - Recent Topics and Applications [Working Title] Pub Date : 2022-01-07 DOI: 10.5772/intechopen.101315

Anna V. Reznik

引用次数: 0